No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditions
|
509 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
509 |
4. Check minimum number of eventsNone |
509 |
5. Include endpoints |
509 |
6. Filter based on genotype QC (FinnGen only) |
470 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
- Control conditions
- not HLP_C3_AML
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Acute myeloid leukaemia, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Acute myeloid leukaemia
- Acute myeloid leukaemia, helper endpoint
- Acute myeloid leukaemia and myelodysplastic syndromes
- Liquid cancers
- Liquid cancers, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 470 | 200 | 270 |
| Unadjusted period prevalence (%) | 0.10 | 0.07 | 0.12 |
| Median age at first event (years) | 68.46 | 65.06 | 70.98 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 509
- Matched controls
- 5090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A04AA01
ATC
ondansetron; systemic, rectal
57.9
317.3
188
51
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
307.7
457
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
307.7
344
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6849.1
307.7
373
*
XW000
NOMESCO Finland
Bone marrow biopsy
148.5
307.7
308
52
WW500
NOMESCO Finland
Blood transfusion
87.5
307.7
202
38
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
53.3
236.7
140
36
127
Kela drug reimbursment
Transplant complication
73.7
166.8
91
15
A05AA02
ATC
ursodeoxycholic acid; oral
54.3
148.6
86
19
Z51.5
ICD-10 Finland
Palliative care
15.1
137.9
137
121
L03AA02
ATC
filgrastim; parenteral
1597.8
131.3
122
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.8
116.3
189
320
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.2
111.3
118
114
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1073.5
94.0
89
*
H02AB02
ATC
dexamethasone; systemic
38.4
92.6
58
17
JN4AD
NOMESCO Finland
Body CT examination
9.9
88.0
114
144
ZX112
NOMESCO Finland
Subcutaneous
42.1
86.9
53
14
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.2
85.5
159
303
J05AB11
ATC
valaciclovir; oral
6.5
84.9
182
399
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
84.8
79
*
R50.9
ICD-10 Finland
Fever, unspecified
6.3
83.0
185
420
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
42.5
82.2
50
13
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
902.6
80.7
77
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
20.4
79.8
63
35
M04AA01
ATC
allopurinol; systemic
5.9
77.9
193
480
J01MA12
ATC
levofloxacin; systemic
5.5
74.2
204
553
L04AD01
ATC
ciclosporin; systemic
29.1
73.4
50
19
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.8
71.3
100
138
JN4BD
NOMESCO Finland
Extensive body CT
10.1
68.2
84
98
ZX120
NOMESCO Finland
Intravenous
8.0
67.2
102
154
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
714.7
65.4
63
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
14.3
65.2
62
49
J02AC03
ATC
voriconazole; systemic
361.7
63.9
63
*
D64.9
ICD-10 Finland
Anaemia, unspecified
5.5
63.9
157
381
L01XX05
ATC
hydroxycarbamide; oral
637.7
58.9
57
*
L01BB02
ATC
mercaptopurine; oral
28.9
58.7
40
15
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
321.4
57.5
57
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.0
56.4
84
123
D70.89
ICD-10 Finland
Neutropenic splenomegaly
111.0
55.1
59
6
N02AA05
ATC
oxycodone; systemic
4.6
54.2
172
508
A04AA02
ATC
granisetron; systemic, transdermal
550.4
51.4
50
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.9
49.4
135
352
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
48.7
46
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
+∞
46.6
44
*
A41.9
ICD-10 Finland
Sepsis, unspecified
7.8
45.6
68
99
121
Kela drug reimbursment
Severe hypofunction of sexual glands
16.8
45.6
39
25
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.7
44.9
43
34
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
465.6
43.9
43
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
228.3
41.5
42
*
TGC00
NOMESCO Finland
Bronchial lavation
9.5
40.3
50
58
WW200
NOMESCO Finland
Immunization
10.4
40.1
46
48
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
70.3
39.8
45
7
B73
ICPC
Leukaemia
+∞
39.1
37
*
J01MA14
ATC
moxifloxacin; systemic
4.9
39.0
99
240
399
Kela drug reimbursment
Venetoclax
+∞
38.0
36
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
36.9
35
*
1518, ,
Kela drug reimbursment
+∞
35.9
34
*
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
35.9
34
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
35.9
34
*
B03XA02
ATC
darbepoetin alfa; parenteral
12.4
35.5
36
31
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
35.3
156
563
L03AA13
ATC
pegfilgrastim; parenteral
193.3
35.2
36
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
34.7
320
1773
L04AA06
ATC
mycophenolic acid; systemic
12.9
34.5
34
28
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
360.1
34.3
34
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
360.1
34.3
34
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.2
34.1
197
835
L01XX52
ATC
venetoclax; oral
+∞
33.7
32
*
J02AC04
ATC
posaconazole; systemic
+∞
33.7
32
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
33.7
32
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.5
33.4
58
99
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
31.6
30
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
30.5
29
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
30.5
29
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
34.1
29.5
38
12
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
29.5
28
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
28.4
27
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.1
27.5
50
89
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.2
27.3
49
86
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
79.7
27.1
30
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.7
26.7
67
159
212
Kela drug reimbursment
Gout
7.8
26.6
38
52
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
26.3
25
*
115
Kela drug reimbursment
Breast cancer
+∞
26.3
25
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
26.3
25
*
J05AB01
ATC
aciclovir; systemic
3.0
26.2
149
613
H02AB09
ATC
hydrocortisone; systemic
8.9
25.1
32
38
GD1AD
NOMESCO Finland
Thorax CT examination
4.9
25.0
58
129
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
10.5
24.9
28
28
D45
ICD-10 Finland
Polycythaemia vera
262.3
24.9
25
*
WW409
NOMESCO Finland
Other aferesis
+∞
23.1
22
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
23.1
22
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
23.1
22
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.3
22.9
64
165
D70.82
ICD-10 Finland
Drug-induced neutropenia
87.5
22.9
25
*
TPH00
NOMESCO Finland
Phlebotomy
125.7
22.8
24
*
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
22.0
21
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
22.0
21
*
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
+∞
22.0
21
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
22.0
21
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
35.5
21.3
27
8
JN6AD
NOMESCO Finland
CT of torso and neck
29.5
21.2
28
10
116
Kela drug reimbursment
Prostate cancer
+∞
21.0
20
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.4
20.6
42
83
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
50.2
20.3
24
5
D64.8
ICD-10 Finland
Other specified anaemias
8.8
20.3
26
31
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.1
20.2
31
46
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
21.9
20.2
29
14
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
19.9
19
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
19.9
19
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
19.9
19
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
19.9
19
*
A41.8
ICD-10 Finland
Other specified sepsis
8.1
19.7
27
35
C90.0
ICD-10 Finland
Multiple myeloma
207.7
19.7
20
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
18.9
62
179
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
18.9
18
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
72.7
18.8
21
*
J02AC01
ATC
fluconazole; systemic
2.4
18.8
200
1094
WF002
NOMESCO Finland
Radical radiotherapy
103.9
18.7
20
*
ZX121
NOMESCO Finland
Central venous catheter
197.0
18.7
19
*
L02AE02
ATC
leuprorelin; implant, parenteral
69.2
17.8
20
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
17.8
17
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
17.8
17
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
17.8
17
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
186.2
17.6
18
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
17.6
59
173
L04AD02
ATC
tacrolimus; systemic
30.0
17.6
23
8
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
17.5
199
1113
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.5
17.3
34
65
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
14.7
17.0
28
20
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
16.9
81
297
ZX090
NOMESCO Finland
Other technic of radiotherapy
65.6
16.8
19
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
16.8
16
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
16.8
16
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
16.8
16
*
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
16.8
16
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
16.6
82
306
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
16.5
198
1125
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.1
16.4
29
50
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.5
16.3
32
61
B02AA02
ATC
tranexamic acid; systemic
3.0
15.7
79
297
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
15.7
15
*
1DB06, ,
NOMESCO Finland
+∞
15.7
15
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
15.7
15
*
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
+∞
15.7
15
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
15.6
167
902
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
164.9
15.6
16
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
15.2
134
665
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.9
15.2
34
73
SPAT1088
SPAT
Blood transfusion
32.8
14.9
19
6
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
58.5
14.9
17
*
J05AX18
ATC
letermovir; oral
+∞
14.7
14
*
130
Kela drug reimbursment
Malignant tumour
+∞
14.7
14
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
14.7
14
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
154.2
14.5
15
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
14.4
37
89
HA1AA
NOMESCO Finland
X-ray mammography
5.3
13.8
28
55
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
13.6
13
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
13.6
13
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
13.6
13
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
35.1
13.6
17
5
L04AA01
ATC
[U] ciclosporin
16.8
13.6
21
13
TAB00
NOMESCO Finland
Lumbar puncture
4.2
13.4
37
94
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.5
13.4
22
35
L02BG04
ATC
letrozole; oral
29.2
13.0
17
6
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
12.7
53
178
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
12.5
12
*
1BC07, ,
NOMESCO Finland
+∞
12.5
12
*
J02AC05
ATC
isavuconazole; systemic
+∞
12.5
12
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
12.5
12
*
A79
ICPC
Malignancy NOS
+∞
12.5
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
12.5
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.5
12
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
133.2
12.5
13
*
L02BA01
ATC
tamoxifen; oral
133.2
12.5
13
*
Y77
ICPC
Malignant neoplasm prostate
133.2
12.5
13
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
12.2
67
263
H02AB06
ATC
prednisolone; systemic
1.9
12.1
255
1734
JN4CD
NOMESCO Finland
Very extensive body CT
10.0
11.9
23
24
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
11.6
80
352
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
11.5
11
*
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
11.5
11
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
11.5
11
*
2AX04, ,
NOMESCO Finland
+∞
11.5
11
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
122.7
11.5
12
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
17.5
11.3
17
10
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
10.8
206
1340
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.7
10.8
25
55
B03XA01
ATC
erythropoietin; parenteral
18.3
10.8
16
9
B01AB05
ATC
enoxaparin; parenteral
2.0
10.7
162
976
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
61.3
10.7
12
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
61.3
10.7
12
*
ZXD05
NOMESCO Finland
Urgent procedure
2.0
10.6
159
954
A40.8
ICD-10 Finland
Other streptococcal sepsis
10.4
10.6
20
20
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
112.2
10.5
11
*
1DB07, ,
NOMESCO Finland
+∞
10.4
10
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
10.4
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.4
10
*
L02BB03
ATC
bicalutamide; oral
+∞
10.4
10
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
10.4
10
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.4
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
23.9
10.3
14
6
A02BC02
ATC
pantoprazole; systemic
1.9
10.1
338
2608
D75.2
ICD-10 Finland
Essential thrombocytosis
40.9
10.0
12
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
40.9
10.0
12
*
J01MA02
ATC
ciprofloxacin; systemic
1.8
10.0
212
1420
H02AB04
ATC
methylprednisolone; systemic
2.2
9.9
90
446
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.1
9.9
21
43
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
26.6
9.9
13
5
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
56.1
9.7
11
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.0
9.6
43
151
D11AH01
ATC
tacrolimus; topical
15.4
9.6
15
10
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
101.9
9.4
10
*
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
30.7
9.4
12
*
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
12.7
9.4
16
13
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
174
Kela drug reimbursment
Ruxolitinib
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
SPAT1074
SPAT
Venesection
37.4
9.0
11
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
9.0
249
1790
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
9.0
53
216
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
50.9
8.7
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
50.9
8.7
10
*
ZXE00
NOMESCO Finland
One hour or less
1.8
8.6
187
1248
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
10.3
8.6
16
16
9872/3-C42.1
ICD-O-3
Acute myeloid leukemia, minimal differentiation of bone marrow
+∞
8.4
8
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
8.4
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
374
Kela drug reimbursment
Ruxolitinib
+∞
8.4
8
*
B74
ICPC
Malignant neoplasm blood other
+∞
8.4
8
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
8.4
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
A07AA09
ATC
vancomycin; oral
9.7
8.3
16
17
R4110
NOMESCO Finland
Physiotherapy
1.9
8.1
135
828
WW200, ,
SPAT
0.4
8.0
54
1095
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
7.9
40
150
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.8
7.7
23
62
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.6
7.7
18
40
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
18.7
7.6
11
6
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
18.7
7.6
11
6
5BA08, ,
NOMESCO Finland
18.7
7.6
11
6
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.1
7.6
31
103
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
25.4
7.6
10
*
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
25.4
7.6
10
*
A07AA02
ATC
nystatin; oral
2.8
7.5
38
143
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
13.6
7.4
12
9
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
7.3
7
*
N05AX08
ATC
risperidone; systemic
0.2
7.3
8
362
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
30.5
7.2
9
*
A98
ICPC
Health maint/preventive medicine
0.6
6.9
363
4134
Z3231
NOMESCO Finland
Registered nurse
1.8
6.9
131
833
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.2
6.9
18
44
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.4
6.9
40
864
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.2
6.8
17
28
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
40.6
6.8
8
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
40.6
6.8
8
*
TPX15
NOMESCO Finland
Removal of vascular injection port
40.6
6.8
8
*
ED1AA
NOMESCO Finland
Mandibular X-ray examination
40.6
6.8
8
*
WVA20
NOMESCO Finland
Medicine administration
4.0
6.8
19
49
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
17.0
6.8
10
6
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
6.7
7
327
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.1
6.7
18
45
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
10.2
6.6
12
12
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.8
6.5
33
124
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.4
6.5
43
185
ZX070
NOMESCO Finland
Intensity modified radiotherapy
70.7
6.4
7
*
L02BG06
ATC
exemestane; oral
70.7
6.4
7
*
WZC30
NOMESCO Finland
Teaching
2.1
6.4
64
328
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
6.4
147
983
ZX100
NOMESCO Finland
Oral
6.7
6.4
15
23
J01FF01
ATC
clindamycin; systemic
1.7
6.3
133
869
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
6.3
29
104
C92
ICD-10 Finland
Myeloid leukaemia
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
6BA02, ,
NOMESCO Finland
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
6.3
6
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
+∞
6.3
6
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
6.3
6
*
L03AB04
ATC
interferon alfa-2a; parenteral
+∞
6.3
6
*
A02BC01
ATC
omeprazole; systemic
1.7
6.3
142
946
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
27.0
6.2
8
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
27.0
6.2
8
*
N05CF01
ATC
zopiclone; oral
1.6
6.2
171
1198
D07AB08
ATC
desonide; topical
2.1
6.2
58
290
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
6.1
38
159
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Proper column names.
- Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV not working.
- No filters and sorters.
- Limited amount of endpoints with TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Refractory anaemia with excess of blasts [RAEB]
D46.2 (45586109)
D46.2 (45586109)
hydroxycarbamide; oral
L01XX05 (21603787)
L01XX05 (21603787)
Bone marrow aspiration report
48807-2 (3048879)
48807-2 (3048879)
Myelodysplastic syndrome, unspecified
D46.9 (45557083)
D46.9 (45557083)
Essential (haemorrhagic) thrombocythaemia
D47.3 (45576400)
D47.3 (45576400)
Other myelodysplastic syndromes
D46.7 (45595762)
D46.7 (45595762)
Acute myeloblastic leukaemia [AML]
C92.0 (45600565)
C92.0 (45600565)
Myeloid leukaemia, Acute
2050A (2000401828)
2050A (2000401828)
Exploration of soft tissue of pelvis, percutaneous
NEA10 (2001307877)
NEA10 (2001307877)
Blood transfusion
WW500 (2001310603)
WW500 (2001310603)
Cystostatic therapy of methastized malignancy
WD105 (2001310678)
WD105 (2001310678)
Multiple cystostatic therapy of methastized malignancy
WD115 (2001310679)
WD115 (2001310679)
Demanding cystostatic therapy of methastized malignancy
WD125 (2001310680)
WD125 (2001310680)
Demanding cystostatic therapy of methastized malignancy
WD135 (2001310681)
WD135 (2001310681)
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 (2001600117)
117 (2001600117)
Karyotype in Bone marrow
81861-7 (21494434)
81861-7 (21494434)
filgrastim; parenteral
L03AA02 (21603851)
L03AA02 (21603851)
Morphology [Interpretation] in Bone marrow Narrative
51628-6 (3042111)
51628-6 (3042111)
Bone marrow Pathology biopsy report
33721-2 (3045142)
33721-2 (3045142)
HTLV I+II Ab panel - Serum
55162-2 (40758292)
55162-2 (40758292)
Acute myeloid leukemia, NOS, of bone marrow
9861/3-C42.1 (44504699)
9861/3-C42.1 (44504699)
Malignant neoplasm of prostate
C61 (45547509)
C61 (45547509)
Acute myelomonocytic leukaemia
C92.5 (45557042)
C92.5 (45557042)
Myeloid leukaemia
C92 (45571570)
C92 (45571570)
Acute promyelocytic leukaemia [PML]
C92.4 (45571572)
C92.4 (45571572)
Acute leukaemia of unspecified cell type
C95.0 (45600572)
C95.0 (45600572)
Chronic myeloproliferative disease
D47.1 (45600598)
D47.1 (45600598)
venetoclax; oral
L01XX52 (1123676)
L01XX52 (1123676)
Drill biopsy of bone marrow, pelvis
TNE25 (2001307884)
TNE25 (2001307884)
Bone marrow biopsy
XW000 (2001310618)
XW000 (2001310618)
Subcutaneous
ZX112 (2001311492)
ZX112 (2001311492)
granisetron; oral, parenteral, transdermal
A04AA02 (21600494)
A04AA02 (21600494)
voriconazole; oral, parenteral
J02AC03 (21603082)
J02AC03 (21603082)
Morphology [Interpretation] in Blood Narrative
18314-5 (3000093)
18314-5 (3000093)
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 (3007080)
31374-2 (3007080)
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 (3007844)
5159-9 (3007844)
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 (3012110)
2589-0 (3012110)
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 (3015635)
7853-5 (3015635)
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 (3016407)
3255-7 (3016407)
Hepatitis A virus Ab [Presence] in Serum
20575-7 (3016650)
20575-7 (3016650)
Segmented neutrophils/Leukocytes in Blood
26505-8 (3017354)
26505-8 (3017354)
Immunofixation for Serum or Plasma
25700-6 (3037756)
25700-6 (3037756)
Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
40724-7 (3040363)
40724-7 (3040363)
Epstein Barr virus Ab [Presence] in Serum
49178-7 (3048929)
49178-7 (3048929)
Oncology Clinic/Center
261QX0200X (38004268)
261QX0200X (38004268)
Medical Oncology
90 (38004507)
90 (38004507)
Body height measure
50373000 (4177340)
50373000 (4177340)
Body mass index
60621009 (4245997)
60621009 (4245997)
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
71668-8 (43055361)
71668-8 (43055361)
Leukaemia, unspecified
C95.9 (45586073)
C95.9 (45586073)
Paranasal sinuses X-ray examination without contrast
DM1AA (2001301740)
DM1AA (2001301740)
Paranasal sinuses X-ray examination in one projection
DM1QA (2001301761)
DM1QA (2001301761)
High resolution CT examination of lungs
GD1DD (2001303632)
GD1DD (2001303632)
Abdominal ultrasound examination
JN3AE (2001305555)
JN3AE (2001305555)
Ultrasound examination of upper extremity veins
PH1AE (2001309445)
PH1AE (2001309445)
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 (2001309601)
TPH20 (2001309601)
Removal of fixed intravenous catheter
TPH90 (2001309607)
TPH90 (2001309607)
Transfer of stem cells from foreign registered donator
WW306 (2001310594)
WW306 (2001310594)
Other aferesis
WW409 (2001310602)
WW409 (2001310602)
Simple enzyme inhibitor or similar therapy of methastized malignancy
WD505 (2001310690)
WD505 (2001310690)
Body CT examination
JN4AD (2001310897)
JN4AD (2001310897)
Extensive body CT
JN4BD (2001310899)
JN4BD (2001310899)
Central venous catheter
ZX121 (2001311496)
ZX121 (2001311496)
Severe hypofunction of sexual glands
121 (2001600120)
121 (2001600120)
Venetoclax
399 (2001600360)
399 (2001600360)
Leukaemia
B73 (2002000284)
B73 (2002000284)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
SMOKING-2-3-0 (2002330113)
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 (21492711)
78445-4 (21492711)
Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
82134-8 (21493195)
82134-8 (21493195)
methylprednisolone; oral, parenteral
H02AB04 (21602732)
H02AB04 (21602732)
posaconazole; oral, parenteral
J02AC04 (21603083)
J02AC04 (21603083)
Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
30076-4 (3000108)
30076-4 (3000108)
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 (3000515)
27811-9 (3000515)
Band form neutrophils/Leukocytes in Blood
26508-2 (3004809)
26508-2 (3004809)
Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
30075-6 (3005156)
30075-6 (3005156)
Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
29910-7 (3006262)
29910-7 (3006262)
Aspergillus sp Ab [Presence] in Serum
7808-9 (3008536)
7808-9 (3008536)
Leukocyte morphology finding [Identifier] in Blood
11156-7 (3008757)
11156-7 (3008757)
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 (3010130)
7852-7 (3010130)
Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
29909-9 (3012158)
29909-9 (3012158)
Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11483-5 (3012202)
11483-5 (3012202)
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 (3012336)
4542-7 (3012336)
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1952-1 (3013201)
1952-1 (3013201)
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 (3013327)
22314-9 (3013327)
Toxoplasma gondii IgG Ab [Units/volume] in Serum
8039-0 (3014959)
8039-0 (3014959)
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 (3017918)
22246-3 (3017918)
Beta-2-Microglobulin [Mass/volume] in Urine
1953-9 (3018081)
1953-9 (3018081)
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 (3019250)
3209-4 (3019250)
Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26009-1 (3019539)
26009-1 (3019539)
Blood group antibody investigation [Interpretation] in Plasma or RBC
14575-5 (3019601)
14575-5 (3019601)
Treponema pallidum Ab [Presence] in Serum
22587-0 (3019832)
22587-0 (3019832)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
22664-7 (3020779)
Hepatitis B virus surface Ab [Units/volume] in Serum
16935-9 (3023421)
16935-9 (3023421)
Erythropoietin (EPO) [Units/volume] in Serum or Plasma
15061-5 (3024172)
15061-5 (3024172)
HLA-A [Type]
13298-5 (3024471)
13298-5 (3024471)
HLA-DR beta [Type]
13306-6 (3024932)
13306-6 (3024932)
Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
29908-1 (3025634)
29908-1 (3025634)
Toxoplasma gondii IgM Ab [Units/volume] in Serum
8040-8 (3027529)
8040-8 (3027529)
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 (3029080)
42810-2 (3029080)
Reagin Ab [Titer] in Serum by VDRL
50690-7 (3029634)
50690-7 (3029634)
Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
50659-2 (3029715)
50659-2 (3029715)
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 (3030692)
50548-7 (3030692)
Thrombin time
3243-3 (3036489)
3243-3 (3036489)
Legionella sp identified in Specimen by Organism specific culture
593-4 (3037692)
593-4 (3037692)
Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
41010-0 (3038297)
41010-0 (3038297)
Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
41009-2 (3038546)
41009-2 (3038546)
Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
41005-0 (3040359)
41005-0 (3040359)
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 (3040853)
40976-3 (3040853)
Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
41003-5 (3041642)
41003-5 (3041642)
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 (3042194)
38917-1 (3042194)
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 (3043849)
43730-1 (3043849)
FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
54447-8 (40757578)
54447-8 (40757578)
Chromosome analysis panel by Banding
62355-3 (40765096)
62355-3 (40765096)
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 (40765161)
62424-7 (40765161)
Neutrophil count
30630007 (4148615)
30630007 (4148615)
Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
72103-5 (42869858)
72103-5 (42869858)
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 (43055120)
72493-0 (43055120)
Acute monocytic leukemia of bone marrow
9891/3-C42.1 (44504709)
9891/3-C42.1 (44504709)
Parainfluenza type 1 nucleic acid detection
222341000000100 (44790047)
222341000000100 (44790047)
Parainfluenza type 2 nucleic acid detection
222351000000102 (44790048)
222351000000102 (44790048)
Parainfluenza type 3 nucleic acid detection
222361000000104 (44790049)
222361000000104 (44790049)
Parainfluenza type 4 nucleic acid detection
810871000000102 (44806118)
810871000000102 (44806118)
Acute lymphoblastic leukaemia [ALL]
C91.0 (45537873)
C91.0 (45537873)
Postprocedural ovarian failure
E89.4 (45566765)
E89.4 (45566765)
Chronic myeloid leukaemia [CML], BCR/ABL-positive
C92.1 (45576367)
C92.1 (45576367)
Bone-marrow transplant rejection
T86.0 (45580470)
T86.0 (45580470)
Thrombocytopenia, unspecified
D69.6 (45581327)
D69.6 (45581327)
Other transplanted organ and tissue status
Z94.8 (45600381)
Z94.8 (45600381)
General psychiatric examination, not elsewhere classified
Z00.4 (45605094)
Z00.4 (45605094)
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 (586526)
94759-8 (586526)
Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
93840-7 (1001833)
93840-7 (1001833)
Drug-induced neutropenia
D70.82 (2000501376)
D70.82 (2000501376)
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA (2001301913)
EB1HA (2001301913)
Standard cardiac ultrasound examination
FM1AE (2001303278)
FM1AE (2001303278)
Flexible bronchoscopy
UGC12 (2001303610)
UGC12 (2001303610)
Thorax X-ray examination
GD1AA (2001303617)
GD1AA (2001303617)
Thorax CT examination
GD1AD (2001303618)
GD1AD (2001303618)
X-ray examination of the lungs in one projection
GD1PA (2001303645)
GD1PA (2001303645)
Supine thorax X-ray examination
GD1QA (2001303648)
GD1QA (2001303648)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
GD1UA (2001303652)
Total mastectomy
HAC20 (2001303934)
HAC20 (2001303934)
Ultrasound examination of upper part of abdomen
JN1AE (2001305517)
JN1AE (2001305517)
Abdominal CT examination
JN3AD (2001305554)
JN3AD (2001305554)
Ultrasound examination of lower leg veins
PH2AE (2001309451)
PH2AE (2001309451)
Phlebotomy
TPH00 (2001309596)
TPH00 (2001309596)
Insertion of central venous catheter through external or internal jugular vein
TPH15 (2001309600)
TPH15 (2001309600)
Allogenic transfer of stem cells from relative
WW302 (2001310592)
WW302 (2001310592)
Multiple adjuvant cytostatic therapy
WB113 (2001310629)
WB113 (2001310629)
Demanding therapy of methastized malignancy with biomodifiers
WD325 (2001310687)
WD325 (2001310687)
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
WD515 (2001310691)
WD515 (2001310691)
Sedation and analgesia
WX002 (2001310758)
WX002 (2001310758)
Treatment plan or consultation
WZC00 (2001310885)
WZC00 (2001310885)
CT of torso and neck
JN6AD (2001310938)
JN6AD (2001310938)
One hour or less
ZXE00 (2001311394)
ZXE00 (2001311394)
Intravenous
ZX120 (2001311495)
ZX120 (2001311495)
Medical doctor
Z2221 (2001311556)
Z2221 (2001311556)
Physiotherapist
Z3226 (2001311560)
Z3226 (2001311560)
Breast cancer
115 (2001600115)
115 (2001600115)
Gout
212 (2001600208)
212 (2001600208)
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
82198-3 (21493466)
82198-3 (21493466)
CD8 cells/Lymphocytes in Specimen
80222-3 (21494814)
80222-3 (21494814)
nystatin; oral
A07AA02 (21600604)
A07AA02 (21600604)
vancomycin; oral
A07AA09 (21600611)
A07AA09 (21600611)
nystatin
D01AA01 (21601911)
D01AA01 (21601911)
desonide
D07AB08 (21602112)
D07AB08 (21602112)
nystatin; vaginal
G01AA01 (21602363)
G01AA01 (21602363)
pegfilgrastim; parenteral
L03AA13 (21603856)
L03AA13 (21603856)
dexamethasone and antiinfectives
S02CA06 (21605178)
S02CA06 (21605178)
Reticulocyte production index
31111-8 (3000012)
31111-8 (3000012)
Epithelial cells [#/volume] in Urine
30383-4 (3000850)
30383-4 (3000850)
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 (3001405)
14135-8 (3001405)
Base excess in Venous blood by calculation
1927-3 (3002032)
1927-3 (3002032)
Metamyelocytes/Leukocytes in Blood
28541-1 (3002179)
28541-1 (3002179)
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 (3002482)
29257-3 (3002482)
Erythrocytes [#/volume] in Urine
30391-7 (3002582)
30391-7 (3002582)
Base excess in Arterial blood by calculation
1925-7 (3003396)
1925-7 (3003396)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
14879-1 (3003458)
ABO and Rh group [Type] in Blood
882-1 (3003694)
882-1 (3003694)
Protein electrophoresis panel - Serum or Plasma
24351-9 (3004588)
24351-9 (3004588)
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 (3005715)
20578-1 (3005715)
IgG [Mass/volume] in Serum or Plasma
2465-3 (3005719)
2465-3 (3005719)
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 (3005772)
29760-6 (3005772)
Vibrio sp identified in Specimen by Organism specific culture
6581-3 (3005988)
6581-3 (3005988)
IgA [Mass/volume] in Serum or Plasma
2458-8 (3007164)
2458-8 (3007164)
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 (3008909)
7974-9 (3008909)
pH of Capillary blood
2745-8 (3009343)
2745-8 (3009343)
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 (3009595)
6521-9 (3009595)
Magnesium [Moles/volume] in Serum or Plasma
2601-3 (3012095)
2601-3 (3012095)
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 (3012477)
23826-1 (3012477)
pH of Venous blood
2746-6 (3012544)
2746-6 (3012544)
Campylobacter sp identified in Specimen by Organism specific culture
6332-1 (3012568)
6332-1 (3012568)
HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
10351-5 (3013180)
10351-5 (3013180)
EKG study
11524-6 (3013512)
11524-6 (3013512)
HLA-DP [Type]
12285-3 (3013862)
12285-3 (3013862)
Protein [Presence] in Urine by Test strip
20454-5 (3014051)
20454-5 (3014051)
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 (3014162)
13956-8 (3014162)
Chloride [Moles/volume] in Serum or Plasma
2075-0 (3014576)
2075-0 (3014576)
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 (3015399)
30248-9 (3015399)
Mycobacterium sp identified in Blood by Organism specific culture
533-0 (3015479)
533-0 (3015479)
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 (3016417)
1805-1 (3016417)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
1798-8 (3016771)
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
22244-8 (3016816)
22244-8 (3016816)
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 (3016881)
29591-5 (3016881)
Myelocytes/Leukocytes in Blood
26498-6 (3017181)
26498-6 (3017181)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
30405-5 (3018095)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
14979-9 (3018677)
Toxoplasma gondii IgA Ab [Units/volume] in Serum
22578-9 (3018921)
22578-9 (3018921)
pH of Specimen
17433-4 (3019225)
17433-4 (3019225)
Folate [Moles/volume] in Red Blood Cells
14731-4 (3019309)
14731-4 (3019309)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
6598-7 (3019800)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
13317-3 (3019902)
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 (3020565)
21363-7 (3020565)
Protein [Mass/volume] in Serum or Plasma
2885-2 (3020630)
2885-2 (3020630)
Body temperature
8310-5 (3020891)
8310-5 (3020891)
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 (3021337)
10839-9 (3021337)
Promyelocytes/Leukocytes in Blood
26524-9 (3021440)
26524-9 (3021440)
Carbon dioxide [Partial pressure] in Venous blood
2021-4 (3021447)
2021-4 (3021447)
Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
29610-3 (3022058)
29610-3 (3022058)
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 (3022250)
14804-9 (3022250)
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 (3023024)
2020-6 (3023024)
Bacteria identified in Blood by Culture
600-7 (3023368)
600-7 (3023368)
Reticulocytes [#/volume] in Blood
14196-0 (3023520)
14196-0 (3023520)
Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13316-5 (3023601)
13316-5 (3023601)
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 (3024403)
4533-6 (3024403)
Salmonella sp identified in Specimen by Organism specific culture
17563-8 (3024522)
17563-8 (3024522)
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 (3025023)
7993-9 (3025023)
Blasts/Leukocytes in Blood
26446-5 (3025159)
26446-5 (3025159)
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 (3025271)
9728-7 (3025271)
Yersinia sp identified in Specimen by Organism specific culture
701-3 (3025468)
701-3 (3025468)
Osmolality of Urine
2695-5 (3026782)
2695-5 (3026782)
Reticulocytes/Erythrocytes in Blood
4679-7 (3027945)
4679-7 (3027945)
IgM [Mass/volume] in Serum or Plasma
2472-9 (3028026)
2472-9 (3028026)
Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20444-6 (3028369)
20444-6 (3028369)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
50554-5 (3029287)
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 (3029879)
51486-9 (3029879)
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 (3030306)
51485-1 (3030306)
Casts [#/volume] in Urine by Automated count
51483-6 (3030467)
51483-6 (3030467)
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 (3030558)
34720-3 (3030558)
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 (3031478)
34645-2 (3031478)
Blasts [#/volume] in Cerebral spinal fluid
35068-6 (3032352)
35068-6 (3032352)
Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
29495-9 (3035401)
29495-9 (3035401)
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 (3038288)
40982-1 (3038288)
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 (3042596)
41001-9 (3042596)
Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
40702-3 (3043649)
40702-3 (3043649)
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 (3043924)
40987-0 (3043924)
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 (3044254)
40988-8 (3044254)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
34487-9 (3044938)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 (3048816)
47598-8 (3048816)
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 (3051714)
48065-7 (3051714)
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 (36031861)
95941-1 (36031861)
Bacteria [Presence] in Urine
87829-8 (36304419)
87829-8 (36304419)
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 (37019628)
92695-6 (37019628)
Immunohistochemistry procedure
117617002 (4035726)
117617002 (4035726)
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
54218-3 (40757349)
54218-3 (40757349)
Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
56990-5 (40760109)
56990-5 (40760109)
HLA-A [Type] by High resolution
57290-9 (40760409)
57290-9 (40760409)
HLA-B [Type] by High resolution
57291-7 (40760410)
57291-7 (40760410)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
57782-5 (40760892)
HLA-DQ beta [Type]
60536-0 (40763590)
60536-0 (40763590)
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
70242-3 (42868716)
70242-3 (42868716)
Myelodysplastic syndrome, NOS, of bone marrow
9989/3-C42.1 (44502674)
9989/3-C42.1 (44502674)
Acute myeloid leukemia without maturation of bone marrow
9873/3-C42.1 (44504706)
9873/3-C42.1 (44504706)
Polycythemia vera of bone marrow
9950/3-C42.1 (44504717)
9950/3-C42.1 (44504717)
Primary myelofibrosis of bone marrow
9961/3-C42.1 (44504718)
9961/3-C42.1 (44504718)
Myelodysplastic syndrome with excess blasts of bone marrow
9983/3-C42.1 (44504724)
9983/3-C42.1 (44504724)
Palliative care
Z51.5 (45547323)
Z51.5 (45547323)
Abnormal findings on diagnostic imaging of lung
R91 (45548995)
R91 (45548995)
Other cytomegaloviral diseases
B25.8 (45556933)
B25.8 (45556933)
Failure and rejection of transplanted organs and tissues
T86 (45561099)
T86 (45561099)
Other streptococcal sepsis
A40.8 (45561701)
A40.8 (45561701)
Sepsis due to other specified staphylococcus
A41.1 (45561702)
A41.1 (45561702)
Erysipelas
A46 (45561706)
A46 (45561706)
Myeloid leukaemia, unspecified
C92.9 (45561878)
C92.9 (45561878)
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y84.8 (45576102)
Y84.8 (45576102)
Fever, unspecified
R50.9 (45582716)
R50.9 (45582716)
Sepsis, unspecified
A41.9 (45585911)
A41.9 (45585911)
Postprocedural testicular hypofunction
E89.5 (45586179)
E89.5 (45586179)
Bacterial infection, unspecified
A49.9 (45590816)
A49.9 (45590816)
Other specified sepsis
A41.8 (45595587)
A41.8 (45595587)
Anaemia, unspecified
D64.9 (45600610)
D64.9 (45600610)
metronidazole and furazolidone
P01AB51 (45893518)
P01AB51 (45893518)
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 (46235759)
76080-1 (46235759)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
77397-8 (46236098)
HLA-C [Type] by High resolution typing
77636-9 (46236302)
77636-9 (46236302)
Office Visit
OMOP4822458 (581477)
OMOP4822458 (581477)
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 (706163)
94500-6 (706163)
letermovir; oral, parenteral
J05AX18 (715920)
J05AX18 (715920)
Hematology
82 (38004501)
82 (38004501)
Differential panel, method unspecified - Blood
69738-3 (42870588)
69738-3 (42870588)
Urate [Moles/volume] in Serum or Plasma
14933-6 (3026493)
14933-6 (3026493)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
34531-4 (3044640)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
14631-6 (3006140)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
26485-3 (3019069)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
1988-5 (3020460)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
26450-7 (3006504)
Basophils/Leukocytes in Blood
30180-4 (3022096)
30180-4 (3022096)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
26478-8 (3002030)
Blood group antibody screen [Presence] in Serum or Plasma
890-4 (3001079)
890-4 (3001079)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
751-8 (3013650)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
26511-6 (3018010)
sulfamethoxazole and trimethoprim
J01EE01 (21602961)
J01EE01 (21602961)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
5894-1 (3033658)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
26449-9 (3013115)
Monocytes [#/volume] in Blood
26484-6 (3001604)
26484-6 (3001604)
Basophils [#/volume] in Blood
26444-0 (3006315)
26444-0 (3006315)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
26474-7 (3019198)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
24357-6 (3037467)
Internal Medicine
11 (38004456)
11 (38004456)
Outpatient Visit
OP (9202)
OP (9202)
INR in Blood by Coagulation assay
34714-6 (3032080)
34714-6 (3032080)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
1742-6 (3006923)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
19072-8 (3016431)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
1995-0 (3021347)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
2951-2 (3019550)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
30385-9 (3002385)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
2823-3 (3023103)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
6768-6 (3035995)
Platelets [#/volume] in Blood
26515-7 (3007461)
26515-7 (3007461)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
30428-7 (3024731)
MCH [Entitic mass]
28539-5 (3035941)
28539-5 (3035941)
Outpatient Hospital
22 (8756)
22 (8756)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
718-7 (3000963)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
26453-1 (3026361)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
20570-8 (3009542)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
26464-8 (3010813)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
1751-7 (3024561)
Short blood count panel - Blood
55429-5 (40758558)
55429-5 (40758558)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
14682-9 (3020564)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
62238-1 (40764999)
Cathetrisation of vein
TPH04 (2001309597)
TPH04 (2001309597)
pH of Serum or Plasma
2753-2 (3018418)
2753-2 (3018418)
Folate [Moles/volume] in Serum or Plasma
14732-2 (3021960)
14732-2 (3021960)
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 (3013721)
1920-8 (3013721)
metoclopramide; oral, parenteral, rectal
A03FA01 (21600484)
A03FA01 (21600484)
Emergency Room Visit
ER (9203)
ER (9203)
CBC panel - Blood by Automated count
58410-2 (40761511)
58410-2 (40761511)
ursodeoxycholic acid; oral
A05AA02 (21600513)
A05AA02 (21600513)
oxycodone; oral, parenteral
N02AA05 (21604260)
N02AA05 (21604260)
Inpatient Visit
IP (9201)
IP (9201)
ciprofloxacin; oral, parenteral
J01MA02 (21603009)
J01MA02 (21603009)
Dentistry
C5 (903277)
C5 (903277)
Inpatient Hospital
21 (8717)
21 (8717)
moxifloxacin; oral, parenteral
J01MA14 (21603021)
J01MA14 (21603021)
ciclosporin; oral, parenteral
L04AD01 (21603924)
L04AD01 (21603924)
HIV 1 and 2 tests - Meaningful Use set
75622-1 (46235355)
75622-1 (46235355)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
28540-3 (3003338)
Extensive structural and functional ultrasound examination of heart
FM1EE (2001303307)
FM1EE (2001303307)
Ferritin [Mass/volume] in Serum or Plasma
2276-4 (3001122)
2276-4 (3001122)
Pneumonia, unspecified
J18.9 (45601123)
J18.9 (45601123)
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 (21602863)
J01CR02 (21602863)
12 lead EKG panel
34534-8 (3044889)
34534-8 (3044889)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
14749-6 (3013826)
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 (43054903)
72160-5 (43054903)
Calcium [Moles/volume] in Serum or Plasma
2000-8 (3015377)
2000-8 (3015377)
valaciclovir; oral
J05AB11 (21603137)
J05AB11 (21603137)
levofloxacin; inhalant, oral, parenteral
J01MA12 (21603019)
J01MA12 (21603019)
Emergency Room and Inpatient Visit
ERIP (262)
ERIP (262)
Bacteria identified in Isolate by Culture
43409-2 (3042936)
43409-2 (3042936)
Biopsy of skin and subcutaneous tissue
TQX10 (2001310152)
TQX10 (2001310152)
Laboratory Visit
OMOP4822461 (32036)
OMOP4822461 (32036)
fluconazole; oral, parenteral
J02AC01 (21603080)
J02AC01 (21603080)
Extended examination of mouth
SAA03 (2001310276)
SAA03 (2001310276)
aciclovir; oral, parenteral
J05AB01 (21603131)
J05AB01 (21603131)
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 (3051552)
54067-4 (3051552)
Supplier / Service Provider
OMOP5117446 (33004)
OMOP5117446 (33004)
enoxaparin; parenteral
B01AB05 (21600976)
B01AB05 (21600976)
Hepatitis B virus core Ab [Presence] in Serum
16933-4 (3021879)
16933-4 (3021879)
Normoblasts [#/volume] in Blood
715-3 (3021589)
715-3 (3021589)
Infectious Disease
44 (38004484)
44 (38004484)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
51480-2 (3031040)
Physiotherapy
R4110 (2001310233)
R4110 (2001310233)
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 (43055554)
72720-6 (43055554)
Essential (primary) hypertension
I10 (45591453)
I10 (45591453)
tacrolimus; oral, parenteral
L04AD02 (21603925)
L04AD02 (21603925)
Bacteria identified in Urine by Culture
630-4 (3026008)
630-4 (3026008)
allopurinol; oral, parenteral
M04AA01 (21604131)
M04AA01 (21604131)
FEV1/FVC
19926-5 (3011505)
19926-5 (3011505)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
19870-5 (3020158)
FEV1
20150-9 (3024653)
20150-9 (3024653)
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X (38003841)
207NI0002X (38003841)
ondansetron; oral, parenteral, rectal
A04AA01 (21600493)
A04AA01 (21600493)
Case Management Agency
251B00000X (38004193)
251B00000X (38004193)
mycophenolic acid; oral, parenteral
L04AA06 (21603896)
L04AA06 (21603896)
metronidazole; oral, rectal
P01AB01 (21604857)
P01AB01 (21604857)
lorazepam; oral, parenteral, sublingual
N05BA06 (21604571)
N05BA06 (21604571)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
2324-2 (3026910)
Upper gastrointestinal surgery
106 (44777669)
106 (44777669)
Hemoglobin [Presence] in Urine by Test strip
5794-3 (3011397)
5794-3 (3011397)
Bacteria identified in Skin by Aerobe culture
620-5 (3007853)
620-5 (3007853)
General Practice Dentistry
1223G0001X (38003675)
1223G0001X (38003675)
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 (3046279)
33959-8 (3046279)
Emergency Medicine
93 (38004510)
93 (38004510)
pH of Urine
2756-5 (3015736)
2756-5 (3015736)
triamcinolone and antiinfectives
S02CA04 (21605176)
S02CA04 (21605176)
Hepatitis C virus Ab [Presence] in Serum
16128-1 (3017143)
16128-1 (3017143)
Scheduled procedure
ZXD10 (2001311387)
ZXD10 (2001311387)
magnesium hydroxide; oral
A02AA04 (21600052)
A02AA04 (21600052)
magnesium hydroxide; oral
G04BX01 (21602658)
G04BX01 (21602658)
Psychiatry
26 (38004469)
26 (38004469)
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 (3019284)
5195-3 (3019284)
Measurement of bone density from two or more locations with X-ray
NK6QA (2001308500)
NK6QA (2001308500)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
4537-7 (3013707)
Nitrite [Presence] in Urine by Test strip
5802-4 (3021601)
5802-4 (3021601)
Ketones [Presence] in Urine by Test strip
2514-8 (3035350)
2514-8 (3035350)
Glucose [Presence] in Urine by Test strip
25428-4 (3009261)
25428-4 (3009261)
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 (3001668)
19875-4 (3001668)
FEV1 --post bronchodilation
20155-8 (3023550)
20155-8 (3023550)
FEV1/FVC --post bronchodilation
69970-2 (42868459)
69970-2 (42868459)
FVC percent change Respiratory system
69982-7 (42868471)
69982-7 (42868471)
FEV1 percent change
69983-5 (42868472)
69983-5 (42868472)
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 (3009201)
3016-3 (3009201)
Albumin [Presence] in Urine by Test strip
50949-7 (3029937)
50949-7 (3029937)
tramadol; oral, parenteral, rectal
N02AX02 (21604298)
N02AX02 (21604298)
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 (3029187)
33762-6 (3029187)
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 (3001308)
22748-8 (3001308)
cefalexin; oral
J01DB01 (21602870)
J01DB01 (21602870)
prednisolone; oral, parenteral
H02AB06 (21602734)
H02AB06 (21602734)
prednisolone
A07EA01 (21600653)
A07EA01 (21600653)
Clinic/Center
261Q00000X (38004207)
261Q00000X (38004207)
Infiltration anesthesia
WX110 (2001310767)
WX110 (2001310767)
macrogol; oral
A06AD15 (21600575)
A06AD15 (21600575)
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 (40763086)
60026-2 (40763086)
amoxicillin; oral, parenteral
J01CA04 (21602823)
J01CA04 (21602823)
pantoprazole; oral, parenteral
A02BC02 (21600097)
A02BC02 (21600097)
Oral Surgery
19 (38004464)
19 (38004464)
Chronic apical periodontitis
K04.5 (45586691)
K04.5 (45586691)
Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
66885-5 (40769539)
66885-5 (40769539)
Fungus identified in Specimen by Culture
580-1 (3000494)
580-1 (3000494)
clindamycin; oral, parenteral
J01FF01 (21602985)
J01FF01 (21602985)
potassium chloride; oral
A12BA01 (21600877)
A12BA01 (21600877)
Urgent procedure
ZXD05 (2001311386)
ZXD05 (2001311386)
Immunization
WW200 (2001310599)
WW200 (2001310599)
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 (3028167)
24467-3 (3028167)
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 (3018251)
14771-0 (3018251)
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 (3004490)
19231-0 (3004490)
calcium (different salts in combination); oral
A12AA20 (21600872)
A12AA20 (21600872)
Cortisol [Moles/volume] in Serum or Plasma
14675-3 (3036481)
14675-3 (3036481)
Gas panel - Capillary blood
24337-8 (3022313)
24337-8 (3022313)
CD4 cells/Lymphocytes in Specimen
80223-1 (21494815)
80223-1 (21494815)
General Practice
1 (38004446)
1 (38004446)
CD3 cells [#/volume] in Blood
8122-4 (3011412)
8122-4 (3011412)
sulfadiazine and trimethoprim
J01EE02 (21602962)
J01EE02 (21602962)
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 (3014037)
8123-2 (3014037)
Pathology report gross observation
24419-4 (3002256)
24419-4 (3002256)
omeprazole; oral, parenteral
A02BC01 (21600096)
A02BC01 (21600096)
Acute upper respiratory infection, unspecified
J06.9 (45562437)
J06.9 (45562437)
dexamethasone; oral, parenteral
H02AB02 (21602730)
H02AB02 (21602730)
Obstetrics / Gynecology
16 (38004461)
16 (38004461)
mercaptopurine
L01BB02 (21601428)
L01BB02 (21601428)
Enterocolitis due to Clostridium difficile
A04.7 (45552153)
A04.7 (45552153)
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 (3019900)
14647-2 (3019900)
oxazepam; oral
N05BA04 (21604569)
N05BA04 (21604569)
cetirizine; oral
R06AE07 (21603497)
R06AE07 (21603497)
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 (3048773)
47210-0 (3048773)
Gynaecological examination (general)(routine)
Z01.4 (45542395)
Z01.4 (45542395)
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 (3023602)
14646-4 (3023602)
zopiclone; oral
N05CF01 (21604654)
N05CF01 (21604654)
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
216
39
95.48
307.65
6.1
1.3
—
—
—
0
0
163
52
45.64
261.36
1.6
1.5
141.90
152.66
au/ml
0.25
41
19
160
58
39.77
246.31
12.8
6.1
436.03
819.33
iu/ml
—
29
6
152
49
43.80
242.28
4.4
3.9
629.62
490.25
u/ml
—
13
8
305
422
16.54
237.69
24.6
2.1
346.70
234.19
u/l
4.82
299
398
147
62
32.93
213.89
1.4
1.3
250.56
201.38
u/ml
0.51
88
29
152
98
21.69
183.99
4.6
1.3
—
—
—
0
0
103
34
37.73
160.94
12.5
2.5
0.78
0.57
%
0.40
98
28
251
422
10.76
160.58
8.3
2.2
60.14
65.94
e9/l
1.14
208
330
205
268
12.13
159.78
3.2
2.1
9.97
11.27
g/l
3.22
200
251
139
99
18.94
158.99
1.7
1.6
—
—
—
0
0
138
97
19.15
158.94
4.3
1.4
—
—
—
0
0
116
63
23.55
150.82
4.9
1.3
—
—
—
0
0
175
217
11.77
140.48
1.5
1.3
1.14
1.19
g/l
0.21
169
207
84
33
30.29
123.25
5.4
1.3
—
—
—
0
0
79
28
33.21
119.87
1.9
1.0
—
—
—
0
0
84
36
27.75
119.37
5.5
1.3
—
—
—
0
0
154
204
10.39
116.17
1.7
1.7
1.52
1.53
g/l
0.06
136
179
247
571
7.46
112.92
15.6
5.1
1.09
1.03
mmol/l
2.96
242
512
94
0
+∞
101.53
1.0
0.0
—
—
—
0
0
72
34
24.50
98.12
1.2
1.0
—
—
—
0
0
242
634
6.37
94.57
4.9
1.9
29.00
29.78
s
1.12
237
612
93
88
12.71
88.15
2.2
1.4
—
—
—
0
0
234
633
5.99
87.19
13.0
2.9
0.80
0.83
mmol/l
3.12
226
586
172
357
6.77
84.93
2.3
1.5
65.79
66.81
g/l
0.87
167
325
67
39
19.63
83.08
4.7
2.4
—
—
—
0
0
155
296
7.09
83.01
4.0
1.5
—
—
—
0
0
302
1075
5.45
80.05
11.5
2.5
309.07
356.33
umol/l
7.29
293
914
66
43
17.49
77.34
2.4
1.4
—
—
—
0
0
68
47
16.54
77.28
2.6
1.3
—
—
—
0
0
79
75
12.28
74.35
2.0
1.3
—
—
—
0
0
56
30
20.85
71.90
1.8
1.4
—
—
—
0
0
58
34
19.12
71.46
6.1
1.1
—
—
—
0
0
58
34
19.12
71.46
6.1
1.1
—
—
—
0
0
58
34
19.12
71.46
6.1
1.1
—
—
—
0
0
70
5
161.86
67.81
1.3
1.0
—
—
—
0
0
233
768
4.75
65.33
5.5
1.9
—
—
—
0
0
45
20
24.59
62.23
1.4
1.7
—
—
—
0
0
45
20
24.59
62.23
1.4
1.6
—
—
—
0
0
44
19
25.25
61.50
7.3
1.1
—
—
—
0
0
44
19
25.25
61.50
7.3
1.1
—
—
—
0
0
44
19
25.25
61.50
7.3
1.1
—
—
—
0
0
44
19
25.25
61.50
7.2
1.1
—
—
—
0
0
82
106
9.03
61.31
1.5
2.2
28.91
12.01
mg/l
1.36
66
99
242
855
4.49
61.19
3.4
1.7
3.86
1.29
mg/l
3.53
219
664
67
71
10.72
58.14
1.3
1.2
191.66
16.89
u/l
4.43
61
62
89
135
7.78
58.03
2.5
1.2
—
—
—
0
0
66
78
9.57
52.73
2.4
1.3
—
—
—
0
0
60
63
10.66
52.28
2.5
1.4
—
—
—
0
0
38
17
24.08
52.25
1.4
1.1
—
—
—
0
0
180
583
4.23
49.64
3.7
1.8
—
—
—
0
0
83
139
6.94
49.13
3.5
3.6
—
—
—
0
0
203
742
3.89
46.73
1.5
1.3
2.42
2.72
g/l
1.59
180
435
36
19
20.31
46.14
2.3
1.8
40.24
47.24
%
0.71
17
11
169
551
4.09
45.72
3.7
1.9
—
—
—
0
0
45
51
9.58
36.84
5.9
1.9
33.24
33.16
pg
0.04
45
51
135
435
3.86
36.29
16.5
2.4
8.14
8.70
umol/l
0.10
130
378
42
9
50.72
35.28
8.8
2.7
1.24
1.22
%
—
42
9
347
2010
3.28
34.86
34.4
4.0
11.43
12.37
umol/l
1.06
342
1895
208
906
3.19
34.42
17.5
2.0
—
—
—
0
0
313
1724
3.12
34.06
18.4
2.4
—
—
estimate
—
0
0
42
12
38.00
33.34
7.4
1.1
—
—
—
0
0
42
12
38.00
33.34
7.4
1.1
—
—
—
0
0
42
12
38.00
33.34
7.4
1.2
—
—
—
0
0
353
2114
3.19
32.49
59.9
6.4
3.22
4.33
e9/l
2.10
335
1820
311
1806
2.86
28.96
18.7
3.9
32.39
35.43
g/l
15.88
302
1669
335
2036
2.89
28.35
30.2
5.6
0.11
0.20
e9/l
23.51
301
1764
55
107
5.64
27.56
3.9
1.2
—
—
—
0
0
37
48
8.23
27.13
5.1
1.1
—
—
—
0
0
37
48
8.23
27.13
5.1
1.1
—
—
—
0
0
37
48
8.23
27.13
5.1
1.1
—
—
—
0
0
316
1897
2.76
26.80
19.4
5.8
1.20
1.21
mmol/l
2.61
306
1713
60
133
4.98
25.95
1.3
1.2
30.38
48.96
mg/l
3.53
51
115
56
117
5.25
25.92
1.3
1.2
1.36
1.41
ratio
0.12
38
72
338
2138
2.73
25.16
23.7
6.2
1.20
1.21
mmol/l
1.35
296
1845
34
44
8.21
24.95
5.4
1.1
—
—
—
0
0
34
45
8.02
24.48
5.4
1.1
—
—
—
0
0
34
45
8.02
24.48
5.4
1.1
—
—
—
0
0
58
133
4.79
24.06
1.3
1.2
26.54
35.72
mg/l
1.59
50
116
30
9
35.30
23.60
2.9
1.3
—
—
—
0
0
30
9
35.30
23.60
2.9
1.3
—
—
—
0
0
32
13
26.16
23.34
1.1
1.3
—
—
—
0
0
32
16
21.25
21.97
2.8
1.3
—
—
—
0
0
32
16
21.25
21.97
2.8
1.3
—
—
—
0
0
66
180
4.06
21.88
7.8
1.6
—
—
—
0
0
40
72
5.94
21.67
2.0
1.3
—
—
—
0
0
60
167
3.94
19.29
3.6
1.5
—
—
—
0
0
143
670
2.58
18.85
1.9
2.5
2.01
2.25
g/l
6.26
137
614
83
293
3.19
18.55
3.7
1.6
—
—
—
0
0
220
1259
2.32
18.52
6.7
2.7
29.38
34.33
u/l
1.50
212
1185
133
614
2.58
17.98
1.9
2.6
36.20
23.07
%
9.21
126
567
22
7
32.75
17.16
2.0
1.1
—
—
—
0
0
39
85
4.89
17.10
1.6
1.7
—
—
—
0
0
23
11
21.82
16.11
2.8
2.3
—
—
—
0
0
23
33
7.25
15.38
2.6
1.3
—
—
—
0
0
26
44
6.17
14.93
3.0
1.7
2.50
10463.90
u/l
—
6
9
35
79
4.68
14.71
1.1
1.3
74.09
302.02
miu/ml
—
7
26
338
2436
2.15
14.67
14.1
4.7
6.81
6.78
mmol/l
0.11
333
2320
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
130
3.79
14.41
3.3
2.9
0.31
0.40
iu/ml
0.75
21
74
19
7
28.11
14.37
1.2
1.1
—
—
—
0
0
66
242
2.98
13.68
1.7
1.5
—
—
—
0
0
197
1186
2.08
13.63
2.3
2.3
2.94
2.86
mg/l
0.16
166
1009
293
2046
2.02
13.29
15.6
18.3
1.28
1.34
inr
1.36
272
1724
271
1846
2.00
13.14
4.3
3.0
711.23
125.71
ug/l
7.01
260
1709
36
96
3.96
12.22
1.1
1.3
—
—
—
0
0
48
158
3.25
11.92
1.2
1.3
0.20
0.42
g/l
0.49
43
138
155
904
2.03
11.32
4.5
4.4
65.92
359.66
ng/l
2.83
127
761
40
123
3.44
11.06
1.3
1.3
0.00
0.00
g/l
-0.00
40
116
197
1275
1.89
10.44
4.0
2.3
47.61
61.55
u/l
2.91
184
1172
53
205
2.77
9.92
4.3
1.4
3.10
2.70
ug/l
0.29
40
151
205
1372
1.83
9.58
5.7
2.1
2.30
2.35
mmol/l
5.08
187
1183
19
22
8.93
9.36
3.7
1.3
—
—
—
0
0
18
20
9.29
9.09
2.3
2.6
1620.56
704.15
u/ml
1.32
18
20
73
345
2.30
8.98
1.8
2.1
0.21
0.20
g/l
0.36
65
315
12
5
24.51
8.94
8.7
1.6
2.08
3.60
%
—
12
5
107
594
2.01
8.73
12.6
6.2
104.75
104.27
mmol/l
0.58
107
594
117
679
1.94
8.37
4.7
3.0
2.67
2.56
e6/l
0.04
64
334
8
0
+∞
8.35
11.0
0.0
—
—
—
0
0
28
82
3.56
8.34
1.6
1.3
—
—
—
0
0
28
82
3.56
8.34
1.6
1.3
—
—
—
0
0
201
1385
1.75
8.21
5.1
3.2
49.48
122.32
e6/l
0.75
161
1067
143
896
1.83
8.04
2.0
1.8
1265.36
1153.08
nmol/l
0.71
127
679
17
23
7.61
7.73
2.6
1.2
—
—
—
0
0
103
1649
0.53
7.65
3.0
1.9
1.68
1.30
mmol/l
4.66
95
1376
29
93
3.25
7.53
2.7
1.3
35.38
1440.53
e6/l
0.67
24
79
16
21
7.83
7.44
2.7
1.3
—
—
—
0
0
331
3877
0.58
7.40
5.3
6.3
2.52
2.59
mmol/l
0.68
309
3557
15
18
8.55
7.36
2.8
1.3
—
—
—
0
0
28
92
3.16
7.00
2.8
1.2
13.17
63.36
e6/l
0.46
23
77
27
87
3.22
6.96
2.3
1.3
3.72
3.98
mmol/l
0.72
27
82
57
272
2.23
6.83
6.8
4.3
1.06
2.15
mmol/l
1.90
48
196
172
1186
1.68
6.73
5.0
3.1
0.65
0.44
e6/l
0.33
133
873
267
2065
1.62
6.56
2.4
2.3
90.55
95.67
pmol/l
1.04
203
1046
318
3725
0.61
6.45
5.9
7.2
39.26
40.21
mmol/mol
1.37
299
3456
326
2655
1.63
6.42
7.0
4.9
222.00
3576.53
e6/l
1.42
11
47
29
103
2.93
6.37
2.7
1.2
498.72
522.99
mg/l
0.10
29
96
205
1510
1.60
6.02
3.1
3.4
1171.24
1638.19
ng/l
1.88
193
1301
83
487
1.84
5.62
5.0
3.6
2.05
1.94
mmol/l
0.09
71
425
327
3766
0.63
5.53
4.9
5.3
1.25
1.45
mmol/l
14.30
302
3442
114
747
1.68
5.25
4.8
2.9
1.73
1.18
e6/l
0.40
64
405
5
0
+∞
5.21
3.4
0.0
8.42
—
ng/l
—
5
0
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
5
0
+∞
5.21
7.8
0.0
—
—
—
0
0
11
16
7.00
4.97
1.6
1.3
—
—
—
0
0
63
353
1.90
4.92
2.3
2.0
80.34
34.25
u/l
0.47
56
287
186
1393
1.53
4.84
2.1
1.8
18.96
20.05
nmol/l
0.48
178
1181
8
7
11.58
4.80
3.0
1.0
—
—
—
0
0
380
4198
0.63
4.76
103.5
23.3
106.90
134.78
g/l
94.25
375
4129
380
4196
0.63
4.71
102.9
23.1
3.59
4.46
e12/l
65.13
372
4070
380
4196
0.63
4.71
103.5
23.6
32.33
40.18
%
79.84
375
4126
380
4196
0.63
4.71
103.1
23.1
156.10
242.23
e9/l
35.36
373
4086
380
4194
0.63
4.66
102.8
23.0
93.68
91.45
fl
10.19
375
4125
335
3797
0.66
4.66
5.4
5.4
4.21
4.48
mmol/l
4.60
315
3494
15
36
4.26
4.55
1.1
1.0
—
—
—
0
0
85
536
1.70
4.48
7.9
6.9
1.32
1.25
mmol/l
0.06
67
441
26
111
2.41
4.06
1.3
1.4
—
—
—
0
0
7
7
10.12
4.02
1.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
20
5.08
3.70
1.3
1.3
—
—
—
0
0
342
3810
0.69
3.69
7.1
5.5
6.04
6.06
mmol/l
0.09
320
3445
8
12
6.75
3.68
1.3
1.2
—
—
—
0
0
14
40
3.57
3.63
1.1
1.3
—
—
—
0
0
378
4130
0.67
3.62
80.7
20.4
80.68
81.98
umol/l
0.37
371
4063
324
3632
0.70
3.48
5.6
5.3
2.06
1.95
mu/l
0.58
303
3301
10
22
4.61
3.44
1.1
1.0
—
—
—
0
0
10
22
4.61
3.44
1.3
1.2
—
—
—
0
0
7
10
7.08
3.37
1.0
1.3
—
—
—
0
0
20
83
2.47
3.34
3.0
1.2
14.52
23.77
iu/l
1.03
15
71
331
3681
0.71
3.22
55.5
14.7
78.22
76.06
ml/min/173m2
1.07
316
3404
8
15
5.40
3.20
1.1
1.0
—
—
—
0
0
8
15
5.40
3.20
1.0
1.3
—
—
—
0
0
118
1555
0.69
3.19
3.5
4.2
6.68
7.85
mg/mmol
0.17
79
991
121
1585
0.69
3.16
2.7
3.4
6.96
7.43
mmol/l
0.60
111
1341
13
44
3.01
3.15
4.0
4.3
—
—
—
0
0
23
106
2.23
3.07
6.7
5.0
1.31
1.70
mg/l
2.28
23
93
16
62
2.63
3.07
1.1
1.4
—
—
—
0
0
5
5
10.08
2.98
1.0
1.6
—
—
—
0
0
374
4057
0.71
2.92
50.1
10.4
26.84
25.04
u/l
1.52
365
3896
59
381
1.62
2.86
3.2
2.4
0.67
0.35
e6/l
0.35
59
360
12
40
3.05
2.71
1.2
1.2
1.60
1.54
u/ml
—
5
13
22
108
2.08
2.55
5.8
3.4
5.45
1.39
index
0.70
16
51
328
3606
0.75
2.52
5.8
4.5
1.53
1.26
mmol/l
7.48
307
3257
208
1750
1.32
2.39
4.0
4.2
31.48
91.76
ng/l
1.03
168
1317
334
3006
1.32
2.33
6.4
4.4
24.08
12.36
mm/h
14.53
319
2757
9
28
3.25
2.31
1.1
2.1
17.12
15.44
umol/l
—
9
23
6
13
4.66
2.27
1.2
1.2
—
—
—
0
0
6
13
4.66
2.27
1.2
1.2
—
—
—
0
0
7
18
3.93
2.26
12.6
3.1
0.71
1.06
index
—
7
18
23
121
1.94
2.24
1.4
1.3
—
—
—
0
0
10
35
2.89
2.22
1.1
1.2
—
—
—
0
0
10
35
2.89
2.22
1.1
1.2
—
—
—
0
0
245
2124
1.30
2.21
4.3
2.7
—
—
—
0
0
376
4029
0.74
2.18
75.8
19.5
3.99
4.00
mmol/l
0.41
371
3932
278
2455
1.29
2.16
4.6
3.2
69.32
48.09
u/l
2.22
264
2268
10
37
2.74
2.08
1.1
1.2
—
—
—
0
0
10
37
2.74
2.08
1.1
1.2
—
—
—
0
0
20
104
1.96
2.03
1.8
1.7
—
—
—
0
0
377
4027
0.75
2.02
67.1
19.4
138.75
139.74
mmol/l
11.14
371
3937
169
1415
1.29
1.94
3.1
2.3
113.10
282.09
u/l
2.31
159
1322
7
22
3.21
1.88
1.3
1.0
—
—
—
0
0
11
46
2.42
1.86
1.6
1.2
—
—
—
0
0
11
46
2.42
1.86
1.2
1.2
3.17
4.74
u/ml
—
6
19
5
12
4.20
1.82
1.0
1.2
—
—
—
0
0
65
870
0.71
1.82
1.3
1.3
0.79
1.33
u/ml
1.09
16
240
16
80
2.03
1.82
2.4
1.7
421.64
16.58
u/ml
0.47
16
59
17
89
1.94
1.72
1.3
1.3
—
—
—
0
0
5
13
3.87
1.72
1.2
1.3
—
—
—
0
0
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
21
119
1.80
1.68
1.4
1.5
16957.21
12982.80
e6/l
0.24
14
81
21
120
1.78
1.64
1.3
1.2
—
—
—
0
0
10
42
2.41
1.62
1.1
1.1
—
—
—
0
0
21
121
1.77
1.61
1.3
1.2
—
—
—
0
0
36
240
1.54
1.60
5.0
3.2
24.47
25.31
mmol/l
0.66
36
233
7
26
2.72
1.58
1.3
1.2
14.00
10.19
u/l
—
7
21
275
3012
0.81
1.56
4.7
4.1
14.74
14.98
pmol/l
0.78
254
2722
16
280
0.56
1.51
1.9
2.1
—
—
—
0
0
9
38
2.39
1.46
4.6
2.0
3.89
100.68
u/ml
—
9
38
70
892
0.75
1.44
3.1
2.9
0.74
0.78
ug/l
0.19
43
597
120
997
1.27
1.43
1.7
1.8
120388797.15
21906369.76
pmol/l
0.38
103
808
10
46
2.20
1.40
1.1
1.2
—
—
—
0
0
6
23
2.63
1.37
1.0
1.3
—
—
—
0
0
69
537
1.33
1.35
1.4
1.5
—
—
—
0
0
0
37
0.00
1.35
0.0
1.6
—
59.53
—
0
30
27
176
1.56
1.34
1.4
1.3
—
—
—
0
0
6
131
0.45
1.30
2.5
2.0
74.83
41.93
nmol/l
—
6
123
5
18
2.79
1.29
5.2
1.1
—
—
—
0
0
15
252
0.58
1.25
1.9
2.0
—
—
—
0
0
10
49
2.06
1.22
1.5
1.2
2250.90
1778.81
e6/l
—
10
32
18
110
1.66
1.17
1.2
1.2
—
—
—
0
0
0
34
0.00
1.16
0.0
1.6
—
0.99
—
0
22
0
34
0.00
1.16
0.0
1.6
—
1.14
—
0
22
0
34
0.00
1.16
0.0
1.6
—
1.01
—
0
22
107
1253
0.82
1.10
4.0
4.1
19.36
24.31
%
2.38
47
602
19
121
1.59
1.07
3.0
3.7
0.87
0.85
nmol/l
0.06
12
102
7
33
2.14
1.06
13.0
2.9
16.86
12.11
index
—
7
18
7
33
2.14
1.06
1.0
1.1
—
—
—
0
0
35
255
1.40
1.06
5.8
3.9
44.50
45.90
%
0.12
35
250
10
178
0.55
1.05
1.2
1.0
—
—
—
0
0
5
107
0.46
1.02
2.8
2.1
186.20
231.35
pmol/l
—
5
100
9
50
1.81
0.97
1.1
1.1
—
1.10
—
0
8
234
2149
1.16
0.95
4.7
4.1
21.56
0.00
estimate
0.49
57
440
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
235
2172
1.15
0.85
4.7
4.1
0.02
0.01
estimate
0.14
51
426
229
2114
1.15
0.84
4.7
4.1
0.00
0.00
estimate
-0.00
55
429
20
140
1.45
0.78
1.4
1.5
1.29
1.14
g/l
1.03
20
134
24
322
0.73
0.75
1.6
1.5
—
—
—
0
0
7
39
1.81
0.72
1.0
1.1
—
—
—
0
0
7
40
1.76
0.71
1.3
1.1
—
—
—
0
0
52
429
1.24
0.70
2.3
2.6
3.96
7.56
ug/l
1.92
45
369
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
9
58
1.56
0.70
2.1
2.3
11.08
10.67
mmol/l
—
9
58
7
42
1.68
0.68
1.0
1.1
—
—
—
0
0
49
404
1.24
0.67
6.9
3.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
143
1556
0.89
0.57
4.4
4.4
1.88
2.08
ug/l
0.50
131
1386
25
318
0.78
0.57
6.6
2.3
56.00
63.47
ml/min/173m2
0.64
11
139
124
1127
1.13
0.56
4.0
3.5
0.00
0.00
estimate
-0.00
40
338
9
62
1.46
0.53
3.9
2.2
1.19
1.19
mmol/l
—
9
62
9
64
1.41
0.51
3.9
2.2
106.33
105.30
mmol/l
—
9
64
60
522
1.17
0.50
3.2
5.3
28.10
32.51
%
2.46
48
327
17
128
1.34
0.48
1.2
1.2
—
26.78
—
0
6
23
182
1.28
0.47
1.3
1.9
4.30
7.75
iu/ml
—
7
45
0
15
0.00
0.41
0.0
1.4
—
8.70
—
0
15
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
8.31
—
0
16
8
59
1.36
0.41
1.1
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
229.09
—
0
11
129
1201
1.10
0.39
4.4
4.2
0.00
0.00
estimate
-0.00
49
395
47
416
1.14
0.34
1.5
1.4
—
—
—
0
0
94
1010
0.91
0.31
4.3
4.4
1.02
1.02
kg/l
0.13
80
659
94
876
1.09
0.29
3.0
2.2
2.44
2.45
mmol/l
0.17
84
762
8
66
1.22
0.27
1.8
3.0
40.54
10.13
pmol/l
—
8
66
13
105
1.24
0.25
1.4
1.3
260.00
315.58
ug/g
—
8
64
378
3843
0.94
0.24
80.5
15.3
34.40
25.44
mg/l
5.39
365
3144
72
670
1.09
0.24
1.3
1.3
1.27
11.49
u/ml
4.46
21
246
26
229
1.14
0.22
5.3
3.6
1.02
1.02
ratio
0.20
26
213
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.9
—
16.42
—
0
13
28
254
1.11
0.16
5.2
2.7
1.30
1.15
%
0.63
28
254
11
129
0.85
0.15
2.0
2.3
—
—
—
0
0
24
217
1.11
0.15
1.1
1.2
68.17
110.66
u/ml
—
6
87
49
519
0.94
0.13
13.4
7.6
—
—
—
0
0
27
250
1.08
0.11
2.9
2.7
0.71
0.63
%
1.07
27
250
165
1614
1.03
0.11
4.3
4.1
0.00
0.03
estimate
1.22
49
344
6
74
0.81
0.07
1.8
1.5
—
—
—
0
0
7
80
0.87
0.07
2.0
1.4
—
—
—
0
0
10
110
0.91
0.05
1.7
2.2
—
—
—
0
0
191
1890
1.02
0.05
3.0
2.5
75.66
78.08
nmol/l
0.60
177
1666
39
402
0.97
0.04
1.5
1.7
1.53
1.53
%
0.01
32
345
73
727
1.00
0.00
1.2
1.3
17.85
32.82
iu/ml
2.56
26
224
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
8
83
0.96
-0.00
1.8
1.7
324.38
306.50
mu/l
—
8
78
0
6
0.00
-0.00
0.0
2.2
—
0.50
—
0
6
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
10
100
1.00
-0.00
2.5
2.4
30.30
36.45
umol/l
—
10
89
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
9.6
—
5.36
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_AML_WIDE – Acute myeloid leukaemia, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).